EP 1333840 B9 20070829 - M. TUBERCULOSIS CHAPERONIN 60.1 AND USES THEREOF
Title (en)
M. TUBERCULOSIS CHAPERONIN 60.1 AND USES THEREOF
Title (de)
M. TUBERCULOSIS CHAPERONIN 60.1 UND SEINE VERWENDUNGEN
Title (fr)
M.TUBERCULOSIS CHAPERONIN 60.1 ET SES UTILISATIONS
Publication
Application
Priority
- GB 0105069 W 20011116
- GB 0028122 A 20001117
Abstract (en)
[origin: WO0240038A2] The invention relates to the use of cpn 10 from <i>Mycobacterium tuberculosis</i>, or functionally equivalent molecules of fragments thereof, in the prevention and/or treatment of allergic conditions such as asthma, rhinitis/hay fever, eczema and anaphylaxis, which conditions are associated with an underlying Th2 cell over-reactivity, or cancerous conditions.
[origin: WO0240038A2] The invention relates to the use of cpn 10 from <i>Mycobacterium tuberculosis , or functionally equivalent molecules of fragments thereof, in the prevention and/or treatment of allergic conditions such as asthma, rhinitis/hay fever, eczema and anaphylaxis, which conditions are associated with an underlying Th2 cell over-reactivity, or cancerous conditions.
IPC 8 full level
A61K 31/711 (2006.01); A61K 48/00 (2006.01); A61K 38/00 (2006.01); A61K 39/00 (2006.01); A61K 39/02 (2006.01); A61K 39/04 (2006.01); A61K 39/05 (2006.01); A61K 39/08 (2006.01); A61K 39/09 (2006.01); A61K 39/10 (2006.01); A61K 39/102 (2006.01); A61K 39/106 (2006.01); A61K 39/112 (2006.01); A61K 39/12 (2006.01); A61K 39/13 (2006.01); A61K 39/145 (2006.01); A61K 39/165 (2006.01); A61K 39/20 (2006.01); A61K 39/205 (2006.01); A61K 39/25 (2006.01); A61K 39/285 (2006.01); A61K 39/29 (2006.01); A61K 39/35 (2006.01); A61K 39/39 (2006.01); A61P 3/10 (2006.01); A61P 5/14 (2006.01); A61P 7/00 (2006.01); A61P 7/04 (2006.01); A61P 7/06 (2006.01); A61P 9/10 (2006.01); A61P 11/00 (2006.01); A61P 11/02 (2006.01); A61P 11/06 (2006.01); A61P 13/12 (2006.01); A61P 17/02 (2006.01); A61P 17/04 (2006.01); A61P 19/02 (2006.01); A61P 19/10 (2006.01); A61P 21/04 (2006.01); A61P 25/00 (2006.01); A61P 27/14 (2006.01); A61P 29/00 (2006.01); A61P 31/04 (2006.01); A61P 31/10 (2006.01); A61P 33/00 (2006.01); A61P 35/00 (2006.01); A61P 37/02 (2006.01); A61P 37/06 (2006.01); A61P 37/08 (2006.01); A61P 43/00 (2006.01); C07K 14/35 (2006.01); C12N 15/09 (2006.01); G01N 33/68 (2006.01)
CPC (source: EP US)
A61K 39/35 (2013.01 - EP US); A61K 39/39 (2013.01 - EP US); A61P 3/00 (2018.01 - EP); A61P 3/10 (2018.01 - EP); A61P 5/14 (2018.01 - EP); A61P 7/00 (2018.01 - EP); A61P 7/04 (2018.01 - EP); A61P 7/06 (2018.01 - EP); A61P 9/10 (2018.01 - EP); A61P 11/00 (2018.01 - EP); A61P 11/02 (2018.01 - EP); A61P 11/06 (2018.01 - EP); A61P 11/08 (2018.01 - EP); A61P 13/12 (2018.01 - EP); A61P 17/00 (2018.01 - EP); A61P 17/02 (2018.01 - EP); A61P 17/04 (2018.01 - EP); A61P 19/02 (2018.01 - EP); A61P 19/10 (2018.01 - EP); A61P 21/04 (2018.01 - EP); A61P 25/00 (2018.01 - EP); A61P 27/02 (2018.01 - EP); A61P 27/14 (2018.01 - EP); A61P 27/16 (2018.01 - EP); A61P 29/00 (2018.01 - EP); A61P 31/00 (2018.01 - EP); A61P 31/04 (2018.01 - EP); A61P 31/10 (2018.01 - EP); A61P 33/00 (2018.01 - EP); A61P 35/00 (2018.01 - EP); A61P 37/02 (2018.01 - EP); A61P 37/04 (2018.01 - EP); A61P 37/06 (2018.01 - EP); A61P 37/08 (2018.01 - EP); A61P 43/00 (2018.01 - EP); A61K 2039/55516 (2013.01 - EP US); A61K 2039/57 (2013.01 - EP US)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated extension state (EPC)
AL LT LV MK RO SI
DOCDB simple family (publication)
WO 0240038 A2 20020523; WO 0240038 A3 20021024; AT E326977 T1 20060615; AT E355845 T1 20070315; AU 1511702 A 20020527; AU 1512302 A 20020527; AU 2002215117 B2 20050519; AU 2002215123 B2 20050519; AU 2381702 A 20020527; CA 2429894 A1 20020523; CA 2429897 A1 20020523; CY 1105619 T1 20101222; CY 1106394 T1 20111012; DE 60119959 D1 20060629; DE 60119959 T2 20070104; DE 60127159 D1 20070419; DK 1333841 T3 20060925; EP 1333840 A2 20030813; EP 1333840 B1 20070307; EP 1333840 B9 20070829; EP 1333841 A2 20030813; EP 1333841 B1 20060524; EP 1693068 A1 20060823; EP 1693068 B1 20160504; ES 2267836 T3 20070316; ES 2585641 T3 20161007; GB 0028122 D0 20010103; GB 0311383 D0 20030625; GB 0311389 D0 20030625; GB 2389852 A 20031224; GB 2389852 B 20050406; GB 2390366 A 20040107; GB 2390366 B 20050413; HK 1060521 A1 20040813; HK 1060970 A1 20040903; JP 2004513925 A 20040513; JP 2004525085 A 20040819; JP 2008174565 A 20080731; JP 2008179646 A 20080807; JP 2008214347 A 20080918; JP 4648955 B2 20110309; JP 4648956 B2 20110309; JP 4890733 B2 20120307; NZ 525858 A 20050225; NZ 525859 A 20041126; PT 1333841 E 20061031; US 2004127438 A1 20040701; US 2004132163 A1 20040708; WO 0240037 A2 20020523; WO 0240037 A3 20020906; WO 0240517 A2 20020523; WO 0240517 A3 20020906
DOCDB simple family (application)
GB 0105084 W 20011116; AT 01983694 T 20011116; AT 01983701 T 20011116; AU 1511702 A 20011116; AU 1512302 A 20011116; AU 2002215117 A 20011116; AU 2002215123 A 20011116; AU 2381702 A 20011116; CA 2429894 A 20011116; CA 2429897 A 20011116; CY 061100817 T 20060619; CY 071100376 T 20070316; DE 60119959 T 20011116; DE 60127159 T 20011116; DK 01983701 T 20011116; EP 01983694 A 20011116; EP 01983701 A 20011116; EP 05077510 A 20011116; ES 01983701 T 20011116; ES 05077510 T 20011116; GB 0028122 A 20001117; GB 0105066 W 20011116; GB 0105069 W 20011116; GB 0311383 A 20011116; GB 0311389 A 20011116; HK 04103315 A 20040512; HK 04103573 A 20040520; JP 2002542409 A 20011116; JP 2002542410 A 20011116; JP 2008037217 A 20080219; JP 2008037290 A 20080219; JP 2008037550 A 20080219; NZ 52585801 A 20011116; NZ 52585901 A 20011116; PT 01983701 T 20011116; US 41688403 A 20031126; US 43205404 A 20040126